cholestatic


Also found in: Thesaurus, Medical, Wikipedia.

cho·le·sta·sis

 (kō′lĭ-stā′sĭs)
n.
Suppression of biliary flow.

cho′le·stat′ic (-stăt′ĭk) adj.

cholestatic

(ˌkəʊləˈstætɪk)
adj
(Pathology) of or relating to cholestasis
Mentioned in ?
References in periodicals archive ?
Farrukh Saeed discussed treatment options for adult Cholestatic Liver Disease.
Idiosyncratic DILI is more common than intrinsic DILI and can be classified into hepatocellular injury, cholestatic injury, mixed hepatocellular-cholestatic injury, and vascular injury.
The ascending pathophysiology of cholestatic liver disease.
Familial intrahepatic cholestasis (FIC) comprises a group of rare cholestatic liver diseases associated with canalicular transport defects resulting predominantly from mutations in ATP8B1, ABCB11 and ABCB4.
The gradual increase in the number of recent studies suggests that prevention of oxidative stress can play a significant role in preventing cholestatic hepatic damage.
EASL Clinical Practice Guidelines: management of cholestatic liver diseases.
5 Specific histological features can help differentiate hepatitis, cholestatic liver disease, steatosis, vascular abnormalities, infectious diseases, and infiltrative or storage diseases.
Splanchnic Th (2) and Th (1) cytokine redistribution in microsurgical cholestatic rats.
Primary Biliary Cirrhosis (PBC) is an idiopathic, cholestatic destruction of intra-hepatic microscopic bile ducts.
have reported tacrolimus induced cholestatic syndrome following pediatric liver transplantation.
Set 1: clinical or biochemical hepatic abnormalities for at least 6 months; clinical or histological stigmata of liver disease; a sibling affected by progressive familial intrahepatic cholestasis or benign recurrent intrahepatic cholestasis; recurrent and episodic cholestatic disease (without identifiable cause) occurring on more than 2 occasions, the episodes of which are separated by at least 3 months.
Data from a Phase 1 study demonstrated the biological activity and safety profile of GS-9674 in healthy volunteers and support the evaluation of this compound in patients with NASH and cholestatic liver disorders.